Document
IPR2020-00440, No. 2001-68 Exhibit - Complaint, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Aug 8, 2019 Dkt No 1 (P.T.A.B. Jul. 9, 2020)
Cite Document
IPR2020-00440, No. 2001-68 Exhibit - Complaint, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Aug 8, 2019 Dkt No 1 (P.T.A.B. Jul. 9, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2009-69 Exhibit - Comparison of Examples 2 and 3 of US Provisional Application No 61014,918 with PI 75 and PI 74 Ex 1003 (P.T.A.B. Jul. 9, 2020)
Cite Document
IPR2020-00440, No. 2009-69 Exhibit - Comparison of Examples 2 and 3 of US Provisional Application No 61014,918 with PI 75 and PI 74 Ex 1003 (P.T.A.B. Jul. 9, 2020)
+ More Snippets
Document
IPR2020-00440, No. 1048-67 Exhibit - Report of Proceedings (P.T.A.B. Jun. 30, 2020)
Cite Document
IPR2020-00440, No. 1048-67 Exhibit - Report of Proceedings (P.T.A.B. Jun. 30, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2001-55 Exhibit - Complaint, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Aug 8, 2019 Dkt No 1 (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2001-55 Exhibit - Complaint, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Aug 8, 2019 Dkt No 1 (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2010-64 Exhibit - Search results from FDA website httpswwwaccessdatafdagovscriptscderdafindexcfm for FDA approved drugs containing paliperidone palmitate (P.T.A.B. J...
Cite Document
IPR2020-00440, No. 2010-64 Exhibit - Search results from FDA website httpswwwaccessdatafdagovscriptscderdafindexcfm for FDA approved drugs containing paliperidone palmitate (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2009-63 Exhibit - Comparison of Examples 2 and 3 of US Provisional Application No 61014,918 with PI 75 and PI 74 Ex 1003 (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2009-63 Exhibit - Comparison of Examples 2 and 3 of US Provisional Application No 61014,918 with PI 75 and PI 74 Ex 1003 (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2003-57 Exhibit - Order, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Dec 13, 2019 Dkt No 43 (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2003-57 Exhibit - Order, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Dec 13, 2019 Dkt No 43 (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2006-60 Exhibit - Stipulation and Order Regarding Infringement of Claims 1 21 of US Patent No 9,439,906, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 734 CCC...
Cite Document
IPR2020-00440, No. 2006-60 Exhibit - Stipulation and Order Regarding Infringement of Claims 1 21 of US Patent No 9,439,906, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 734 CCC MF DNJ June 8, 2
+ More Snippets
Document
IPR2020-00440, No. 2008-62 Exhibit - Excerpts of Mylans Initial Invalidity Contentions, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Dec 20, 2019 (P.T.A.B. Jun. 19, 2020...
Cite Document
IPR2020-00440, No. 2008-62 Exhibit - Excerpts of Mylans Initial Invalidity Contentions, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Dec 20, 2019 (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2002-56 Exhibit - Excerpts of Janssens Preliminary Responses to Mylans Initial Invalidity Contentions with Respect to US Patent No 9,439,906, Janssen Pharm, Inc v Mylan Labs Ltd, No
Cite Document
IPR2020-00440, No. 2002-56 Exhibit - Excerpts of Janssens Preliminary Responses to Mylans Initial Invalidity Contentions with Respect to US Patent No 9,439,906, Janssen Pharm, Inc v Mylan Labs Ltd, No
+ More Snippets
Document
IPR2020-00440, No. 2012-66 Exhibit - Declaration of Joong Youn Jay Cho (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2012-66 Exhibit - Declaration of Joong Youn Jay Cho (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2011-65 Exhibit - FDA Summary Review for Invega Trinza¿¿ available at httpswwwaccessdatafdagovdrugsatfda docsnda2015207946Orig1s000SumRpdf (P.T.A.B. Jun. 19, 2...
Cite Document
IPR2020-00440, No. 2011-65 Exhibit - FDA Summary Review for Invega Trinza¿¿ available at httpswwwaccessdatafdagovdrugsatfda docsnda2015207946Orig1s000SumRpdf (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2005-59 Exhibit - Scheduling Order, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 734 CCC MF DNJ June 11, 2020 Dkt No 90 (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2005-59 Exhibit - Scheduling Order, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 734 CCC MF DNJ June 11, 2020 Dkt No 90 (P.T.A.B. Jun. 19, 2020)
+ More Snippets
Document
IPR2020-00440, No. 2007-61 Exhibit - Excerpts of Teva¿¿¿s Preliminary Invalidity Contentions with Respect to US Patent No 9,439,906, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 73...
Cite Document
IPR2020-00440, No. 2007-61 Exhibit - Excerpts of Teva¿¿¿s Preliminary Invalidity Contentions with Respect to US Patent No 9,439,906, Janssen Pharm, Inc v Teva Pharm USA, Inc, No 218 cv 734 CCC MF DNJ
+ More Snippets
Document
IPR2020-00440, No. 2004-58 Exhibit - Joint Proposed Discovery Plan, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Nov 8, 2019 Dkt No 34 1 (P.T.A.B. Jun. 19, 2020)
Cite Document
IPR2020-00440, No. 2004-58 Exhibit - Joint Proposed Discovery Plan, Janssen Pharm, Inc v Mylan Labs Ltd, No 219 cv 16484 CCC MF DNJ Nov 8, 2019 Dkt No 34 1 (P.T.A.B. Jun. 19, 2020)
+ More Snippets